• 3718 Citations
  • 35 h-Index
20072020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Naveen Pemmaraju is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 44 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia

Bose, P., Verstovsek, S., Cortes, J. E., Tse, S., Gasior, Y., Jain, N., Jabbour, E. J., Estrov, Z., Alvarado, Y., DiNardo, C. D., Pemmaraju, N., Kornblau, S. M., Kadia, T. M., Daver, N. G., Naqvi, K., Short, N. J., Masarova, L., Villareal, J., Pierce, S. A., Nogueras-Gonzalez, G. & 4 others, Huang, X., Garcia-Manero, G., Kantarjian, H. M. & Ravandi, F., Sep 1 2020, In : Leukemia. 34, 9, p. 2489-2492 4 p.

Research output: Contribution to journalLetter

1 Scopus citations

Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm

Pemmaraju, N. & Konopleva, M., Aug 25 2020, In : Blood Advances. 4, 16, p. 4020-4027 8 p.

Research output: Contribution to journalArticle

Open Access